| Title: |
Dysregulation of Non-Coding RNAs: Roles of miRNAs and lncRNAs in the Pathogenesis of Multiple Myeloma |
| Authors: |
Ismail, Nor Hayati; Mussa, Ali; Al-Khreisat, Mutaz Jamal; Mohamed Yusoff, Shafini; Husin, Azlan; Al-Jamal, Hamid Ali Nagi; Johan, Muhammad Farid; Islam, Md Asiful |
| Contributors: |
WHO Collaborating Centre for Global Women’s Health, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK; Department of Haematology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian 16150, Kelantan, Malaysia. |
| Source: |
9 ; 6 ; 68 |
| Publisher Information: |
MDPI AG |
| Publication Year: |
2023 |
| Collection: |
University of Wolverhampton: Wolverhampton Intellectual Repository and E-Theses (WIRE) |
| Subject Terms: |
dysregulation; long non-coding RNAs; microRNAs; multiple myeloma; non-coding RNAs; Pathogenesis |
| Description: |
© 2024 The Authors. Published by MDPI. This is an open access article available under a Creative Commons licence. The published version can be accessed at the following link on the publisher’s website: https://doi.org/10.3390/ncrna9060068 ; The dysregulation of non-coding RNAs (ncRNAs), specifically microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), leads to the development and advancement of multiple myeloma (MM). miRNAs, in particular, are paramount in post-transcriptional gene regulation, promoting mRNA degradation and translational inhibition. As a result, miRNAs can serve as oncogenes or tumor suppressors depending on the target genes. In MM, miRNA disruption could result in abnormal gene expression responsible for cell growth, apoptosis, and other biological processes pertinent to cancer development. The dysregulated miRNAs inhibit the activity of tumor suppressor genes, contributing to disease progression. Nonetheless, several miRNAs are downregulated in MM and have been identified as gene regulators implicated in extracellular matrix remodeling and cell adhesion. miRNA depletion potentially facilitates the tumor advancement and resistance of therapeutic drugs. Additionally, lncRNAs are key regulators of numerous cellular processes, such as gene expression, chromatin remodeling, protein trafficking, and recently linked MM development. The lncRNAs are uniquely expressed and influence gene expression that supports MM growth, in addition to facilitating cellular proliferation and viability via multiple molecular pathways. miRNA and lncRNA alterations potentially result in anomalous gene expression and interfere with the regular functioning of MM. Thus, this review aims to highlight the dysregulation of these ncRNAs, which engender novel therapeutic modalities for the treatment of MM. ; This work was supported by the GIPS-PhD (311/PPSP/4404822) research grant from Universiti Sains Malaysia awarded to M.F.J. and N.H.I. ; Published version |
| Document Type: |
article in journal/newspaper |
| File Description: |
application/pdf |
| Language: |
English |
| Relation: |
https://www.mdpi.com/2311-553X/9/6/68; 37987364 (pubmed); http://hdl.handle.net/2436/625658 |
| DOI: |
10.3390/ncrna9060068 |
| Availability: |
http://hdl.handle.net/2436/625658; https://doi.org/10.3390/ncrna9060068 |
| Rights: |
Licence for published version: Creative Commons Attribution 4.0 International ; http://creativecommons.org/licenses/by/4.0/ |
| Accession Number: |
edsbas.60DDBB61 |
| Database: |
BASE |